Fenbendazole.org: Intersect.rar

Research indicating that the drug may target cancer stem cells, which are often resistant to standard treatments. Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer .

The drug interferes with tubulin polymerization, a process essential for cancer cell division. Fenbendazole.org intersect.rar

The American Cancer Society and other health authorities emphasize that while laboratory studies exist, Fenbendazole is not FDA-approved for human use, and large-scale clinical trials are still needed to confirm its safety and efficacy in people. Research indicating that the drug may target cancer

Source: Nature Scientific Reports / PubMed Central Date: August 9, 2018 Key Findings: 2018 Key Findings: